ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 70

The Odds of Work Disability, Unemployment and Depending on Living Allowances Are More Influenced By the Number of Morbidities Than By the Presence of a Musculoskeletal Disease

Antje van der Zee-Neuen1, Polina Putrik2, Sofia Ramiro3, Andras Keszei4, Rob de Bie5, Astrid M. Chorus6 and Annelies Boonen7, 1Internal Medicine, Rheumatology, Maastricht University, Maastricht, Netherlands, 2Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 3Rheumatology, Amsterdam Rheumatology Center, University of Amsterdam & Hospital Garcia de Orta, Almada, Portugal, Amsterdam, Netherlands, 4Medical Informatics, RWTH Aachen University, Aachen, Germany, 5Epidemiology, Maastricht University, Maastricht, Netherlands, 6Netherlands Organization for Applied Scientific Research, Leiden, Netherlands, 7Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Co-morbidities, Employment, Musculoskeletal and Work Disability

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Public Health: Osteoporosis, Non-Inflammatory Arthritis and More

Session Type: Abstract Submissions (ACR)

Background/Purpose:  The prevalence of multimorbidity (≥ 2 chronic morbidities in 1 person), is increasingly common also in patients at working age. Musculoskeletal diseases (MSKD) are among the most frequently occurring chronic diseases and comorbidities. However, little is known about the association of multimorbidity with official work disability and even less about its association with economic unemployment or dependence on living allowances (LA). Also, the additional influence of MSKD as comorbidity is unclear. We aimed to explore 1) whether an increasing number of morbidities is associated with increased odds to be work disabled (WD), unemployed or depending on LA & 2) whether presence of MSKD is associated with these outcomes or has an important additional contribution when combined with other morbidities.

Methods: In a Dutch epidemiological study, 8904 subjects (≥18 years old) completed a questionnaire on socio-demographic and lifestyle factors, self-reported physician-diagnosed diseases & work status. Persons at working age (18-65 years) who were either employed, formally WD, economically unemployed or receiving LA were included in the analyses (n=5396). Two multinomial regression models were computed with work status (i.e. employed, WD, unemployed or LA) as outcome and adjusted for age, gender, education, body mass index and smoking status. In model 1 the number of morbidities was the independent variable of interest and in model 2 either the single diseases (distinguishing MSKD from all other single diseases) or combinations of 2 or ≥3 diseases, including and excluding MSKD. Paid employment was used as reference outcome and estimates were compared to the healthy.

Results: MSKD occurred in 925 cases (17%) of the sample. Multimorbidity was present in 755 cases (14%). Of all cases with 2 morbidities 265/490 (54%) reported a MSKD. In cases with ≥3 morbidities 198/265 (75%) reported a MSKD .The odds to be WD increased steeply with every additional morbidity and the same trend but less pronounced was seen for unemployment and dependence on a LA (Table 1). Small (but no significant) increments were seen when exploring the role of MSKD in multimorbidity (e.g. the odds to be WD were 9.2 times higher than to be employed for persons suffering from 2 morbidities including MSKD and these odds were somewhat lower (8.8) when none of the 2 morbidities was MSKD). The odds to be unemployed or to receive a LA were slightly (but not significantly) higher for persons suffering from 2 co-occurring morbidities when 1 of these was a MSKD compared to 2 co-occurring morbidities without MSKD. (Table 1)

Conclusion:  An increasing number of morbidities is associated with increased odds of WD, and to a lesser extent also with unemployment and dependence on a LA. There is a small additional adverse influence of the co-occurrence of MSKD in those suffering from 2 morbidities on all work outcomes. Multimorbidity requires more attention in considering patients’ work outcome.

Table 1   Association of multimorbidity and combinations with and
without MSKD with employment status

                                                                                                                                                         N=5396

Number of morbiditiesϮ

OR [95% CI]

Type of morbidities
(in- or excluding MSKD)Ϯ

OR [95% CI]

Unemployed*                                      n=184

Unemployed*                                      n=184

1

1.32 [0.92;1.88]

1 morbidity (MSKD)

1.23 (0.71; 2.14)

2

2.55 [1.63;4.00]

1 morbidity (no MSKD)

1.36 (0.91; 2.02)

3

3.08 [1.60;5.92]

2 morbidities (+ MSKD)

2.66 (1.51; 4.68)

≥4

 4.50 [1.58;13.62]

2 morbidities (no MSKD)

2.43 (1.31; 4.51)

≥3 morbidities (+ MSKD)

3.21 (1.62; 6.35)

≥3 morbidities (no MSKD)

3.58 (1.34; 9.54)

Work disabled*                                  n=350

Work disabled*                                  n=350

1

3.31 [2.35;4.65]

1 morbidity (MSKD)

2.00 (1.19; 3.39)

2

 9.16 [6.32;13.27]

1 morbidity (no MSKD)

3.91 (2.73; 5.60)

3

14.03 [8.88; 22.16]

2 morbidities (+ MSKD)

9.22 (5.98; 14.23)

≥4

30.33 [14.87; 61.85]

2 morbidities (no MSKD)

8.84 (5.59; 14.00)

≥3 morbidities (+ MSKD)

23.73 (15.42; 36.53)

≥3 morbidities (no MSKD)

14.89 (7.73; 28.71)

Living allowance*                             n=57

Living allowance*                             n=57

1

1.46 [0.69; 3.10]

Musculoskeletal disease

1.39 (0.49; 3.99)

2

3.76 [1.67; 8.46]

1 morbidity (no MSKD)

1.48 (0.64; 3.47)

3

  6.37 [2.46; 16.51]

2 morbidities (+ MSKD)

5.61 (2.32; 13.55)

≥4

16.29 [4.94; 53.67]

2 morbidities (no MSKD)

1.74 (0.47; 6.54)

≥3 morbidities (+ MSKD)

7.70 (3.05; 19.45)

≥3 morbidities (no MSKD)

10.45 (2.86; 38.13)

*  Paid work is reference outcome (n=4805)
Ϯ  No morbidity is reference category                          Significant results are bold (p≤0.05)
                       

Models adjusted for age, gender, education, body-mass index & smoking status


Disclosure:

A. van der Zee-Neuen,
None;

P. Putrik,
None;

S. Ramiro,
None;

A. Keszei,
None;

R. de Bie,
None;

A. M. Chorus,
None;

A. Boonen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-odds-of-work-disability-unemployment-and-depending-on-living-allowances-are-more-influenced-by-the-number-of-morbidities-than-by-the-presence-of-a-musculoskeletal-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology